| Price | 258.00p on 18-07-2025 at 18:20:06 |
|---|---|
| Change | 6.00p 2.38% |
| Buy | 262.00p |
| Sell | 255.00p |
| Buy / Sell HCM Shares | |
| Last Trade: | Sell 4,084.00 at 258.00p |
| Day's Volume: | 56,253 |
| Last Close: | 258.00p |
| Open: | 260.00p |
| ISIN: | KYG4672N1198 |
| Day's Range | 254.00p - 263.00p |
| 52wk Range: | 187.50p - 336.00p |
| Market Capitalisation: | £2.21b |
| VWAP: | 261.00428p |
| Shares in Issue: | 855.39m |
Sector: Medicine and Biotech
Listed In: FTSE AIM 100, FTSE AIM All-Share,
Hutchmed (HCM) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Sell* | 4,084 | 258.00p | Uncrossing Trade |
16:35:08 - 18-Jul-25 |
| Buy* | 189 | 261.40p | Ordinary |
16:20:43 - 18-Jul-25 |
| Sell* | 377 | 256.00p | Automatic Execution |
16:00:07 - 18-Jul-25 |
| Sell* | 1 | 255.90p | Ordinary |
15:23:35 - 18-Jul-25 |
| Buy* | 13 | 262.20p | Ordinary |
15:23:35 - 18-Jul-25 |
| Buy* | 13 | 262.20p | Ordinary |
15:11:33 - 18-Jul-25 |
| Sell* | 85 | 254.00p | SI Trade |
10:10:00 - 18-Jul-25 |
| Sell* | 551 | 255.00p | SI Trade |
10:09:59 - 18-Jul-25 |
| Sell* | 46 | 254.00p | Automatic Execution |
10:09:59 - 18-Jul-25 |
| Sell* | 3,019 | 255.00p | Automatic Execution |
10:09:59 - 18-Jul-25 |
Hutchmed (HCM) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 3rd Jul 2025 9:30 am | RNS | HUTCHMED to Announce 2025 Half-Year Results |
| 2nd Jul 2025 10:00 am | RNS | Update on Joint Corporate Brokers in London |
| 30th Jun 2025 9:30 am | RNS | China Approval based on Phase III SACHI Trial |
| 30th Jun 2025 9:30 am | RNS | Total Voting Rights |
| 30th Jun 2025 9:30 am | RNS | Blocklisting Six Monthly Return |
| 10th Jun 2025 11:00 am | RNS | Grant of Share Options and Awards under LTIP |
| 5th Jun 2025 7:00 am | RNS-R | HUTCHMED and Innovent Announce NDA Acceptance |
| 2nd Jun 2025 7:00 am | RNS-R | HUTCHMED Highlights SACHI Phase III Data at ASCO |
| 30th May 2025 9:30 am | RNS | Total Voting Rights |
| 23rd May 2025 7:00 am | RNS-R | HUTCHMED Highlights Data to be Presented at ASCO |
